XOMA 052 Phase 1 Data to be Presented At European Association for the Study of Diabetes Annual Meeting
July 15, 2008 07:30 ET
|
XOMA Corporation
BERKELEY, Calif., July 15, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced that results from two ongoing Phase 1...
XOMA to Present At the Jefferies Healthcare Conference On June 26
June 19, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., June 19, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS
June 07, 2008 14:00 ET
|
XOMA Corporation
SAN FRANCISCO, June 7, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today at the Federation of Clinical Immunology Societies 2008 FOCIS Annual Meeting that a study of XOMA 052 in a mouse...
XOMA 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At ADA
June 07, 2008 13:00 ET
|
XOMA Corporation
SAN FRANCISCO, June 7, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today at the American Diabetes Association's 68th Scientific Sessions that a study of XOMA 052, a potent...
XOMA to Present At the Needham Biotechnology and Medical Technology Conference On June 11
June 05, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., June 5, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA to Present At the Rodman and Renshaw Global Healthcare Conference On May 20
May 14, 2008 16:35 ET
|
XOMA Corporation
BERKELEY, Calif., May 14, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that David Boyle, Vice President of...
XOMA Reports First Quarter 2008 Financial Results
May 12, 2008 06:06 ET
|
XOMA Corporation
BERKELEY, Calif., May 12, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended March...
XOMA Refinances Royalty-Based Loan Facility for $55 Million
May 12, 2008 06:05 ET
|
XOMA Corporation
BERKELEY, Calif., May 12, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that it has entered into an amended loan...
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12
May 05, 2008 08:05 ET
|
XOMA Corporation
BERKELEY, Calif., May 5, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call...
XOMA Announces New Audit Committee Member
April 01, 2008 17:30 ET
|
XOMA Corporation
BERKELEY, Calif., April 1, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that XOMA's Board of Directors has appointed Board member William K. Bowes, Jr. to its Audit Committee. The...